Tuberculous meningitis: many questions, too few answers.

Tuberculous meningitis (TM) is difficult to diagnose and treat; clinical features are non-specific, conventional bacteriology is widely regarded as insensitive, and assessment of newer diagnostic methods is not complete. Treatment includes four drugs, which were developed more than 30 years ago, and...

Full description

Bibliographic Details
Main Authors: Thwaites, G, Tran, T
Format: Journal article
Language:English
Published: 2005
_version_ 1797065916457943040
author Thwaites, G
Tran, T
author_facet Thwaites, G
Tran, T
author_sort Thwaites, G
collection OXFORD
description Tuberculous meningitis (TM) is difficult to diagnose and treat; clinical features are non-specific, conventional bacteriology is widely regarded as insensitive, and assessment of newer diagnostic methods is not complete. Treatment includes four drugs, which were developed more than 30 years ago, and prevents death or disability in less than half of patients. Mycobacterium tuberculosis resistant to these drugs threatens a return to the prechemotherapeutic era in which all patients with TM died. Research findings suggest that adjunctive treatment with corticosteroids improve survival but probably do not prevent severe disability, although how or why is not known. There are many important unanswered questions about the pathophysiology, diagnosis, and treatment of TM. Here we review the available evidence to answer some of these questions, particularly those on the diagnosis and treatment of TM.
first_indexed 2024-03-06T21:35:09Z
format Journal article
id oxford-uuid:45fbf1cf-a9b1-49d1-9f20-91c7feeb4c84
institution University of Oxford
language English
last_indexed 2024-03-06T21:35:09Z
publishDate 2005
record_format dspace
spelling oxford-uuid:45fbf1cf-a9b1-49d1-9f20-91c7feeb4c842022-03-26T15:11:06ZTuberculous meningitis: many questions, too few answers.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:45fbf1cf-a9b1-49d1-9f20-91c7feeb4c84EnglishSymplectic Elements at Oxford2005Thwaites, GTran, TTuberculous meningitis (TM) is difficult to diagnose and treat; clinical features are non-specific, conventional bacteriology is widely regarded as insensitive, and assessment of newer diagnostic methods is not complete. Treatment includes four drugs, which were developed more than 30 years ago, and prevents death or disability in less than half of patients. Mycobacterium tuberculosis resistant to these drugs threatens a return to the prechemotherapeutic era in which all patients with TM died. Research findings suggest that adjunctive treatment with corticosteroids improve survival but probably do not prevent severe disability, although how or why is not known. There are many important unanswered questions about the pathophysiology, diagnosis, and treatment of TM. Here we review the available evidence to answer some of these questions, particularly those on the diagnosis and treatment of TM.
spellingShingle Thwaites, G
Tran, T
Tuberculous meningitis: many questions, too few answers.
title Tuberculous meningitis: many questions, too few answers.
title_full Tuberculous meningitis: many questions, too few answers.
title_fullStr Tuberculous meningitis: many questions, too few answers.
title_full_unstemmed Tuberculous meningitis: many questions, too few answers.
title_short Tuberculous meningitis: many questions, too few answers.
title_sort tuberculous meningitis many questions too few answers
work_keys_str_mv AT thwaitesg tuberculousmeningitismanyquestionstoofewanswers
AT trant tuberculousmeningitismanyquestionstoofewanswers